Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA)
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Business Wire
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of CareDx, Inc. (“CareDx” or the “Company”) (NASDAQ: CDNA) investors concerning the Company and its officers’ possible violations of federal securities laws.If you are a shareholder who suffered a loss, click here to participate.If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.On July 16, 2019, Kerrisdale Capital Research released a report alleging, among other things, that the Company’s diagnostic test, AlloSure, is “fundamentally incapable of identifying the most common type of kidney rejection.” Moreover, the report stated that AlloSure revenues are derived from “protocol usage in clinical testing, w
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business Wire
- CareDx, Inc (NASDAQ: CDNA) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock.MarketBeat
- CareDx to Report First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- CareDx to Report First Quarter 2024 Financial ResultsBusiness Wire
CDNA
Earnings
- 2/28/24 - Beat
CDNA
Sec Filings
- 5/3/24 - Form 4
- 5/3/24 - Form 3
- 5/3/24 - Form 4
- CDNA's page on the SEC website